Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
did you ever get a return call from Gribble?
noticed a few updates on yahoo finance?
Everyone appears to be bailing out?????????
Form 8-K for PHYTOMEDICAL TECHNOLOGIES INC
--------------------------------------------------------------------------------
24-Jun-2010
Change in Directors or Principal Officers
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On June 17, 2010, Mr. Raymond Krauss tendered his resignation as a Director and officer of PhytoMedical Technologies, Inc. (the "Company") effective as of that date. Of the 200,000 options previously granted to Mr. Krauss pursuant to the terms of the Stock Option Agreement dated March 15, 2010 (the "Krauss SOA"), none have vested, and accordingly, pursuant to the terms of the Krauss SOA, all of such options have been terminated.
On June 17, 2010, Mr. Greg Wujek tendered his resignation as a Director of the Company effective as of that date. Of the 400,000 options previously granted to Mr. Wujek pursuant to the terms of the Stock Option Agreement dated March 15, 2010 (the "Wujek SOA"), 200,000 have vested (the "Vested Options") in accordance with the terms of the Wujek SOA may be exercised through a date that is 90 days from June 17, 2010. The remaining 200,000 options granted to Mr. Wujek pursuant to the Wujek SOA have not vested and, in accordance with the terms of the Wujek SOA, are terminated.
The resignations of Messrs. Kruass and Wujek were not due to any disagreement between the Company and each of Messrs. Krauss and Wujek.
On June 22, 2010, in order to fill the vacancies created by the resignation of Mr. Krauss, the Board of Directors appointed Mr. Amit S. Dang to serve as the Company's Interim CFO, Treasurer, and Secretary. Mr. Dang currently serves as the Company's President and Chief Executive Officer.
Did you ever find a reason for the Lynch and Branning departure and the Dang/Sidhu appointments. From what I see these are Rayat Harmels boys from over at Hepalife -another primary Rayat holding. Not sure if Rayat was not happy with the 200 million increase and how they were handling it or if Lynch and Branning found something out and bailed?????
Is the cancer formualtion still viable for production and what about the China end of things? A PR update would be nice!
Nice! I anticipate Dr. Lynch is also pursuing India.
Wolrd populations:
1 China 1,336,970,000 - 19.62%
2 India 1,179,618,000 - 17.31%
3 United States 309,075,000 - 4.54%
http://en.wikipedia.org/wiki/List_of_countries_by_population
NITE has been doing some odd things with the bid/ask lately. Would like to see them stay at or above the .05 ask
Nice. Did you use the investors link on the PHYTO home page for contacting him or do you have a direct email for him.
Thanks
Hey Chilar add me as an assistant to the board if you wish.
GLTY
Very interesting!
Termination of a Material Definitive Agreement
Item 1.02. Termination of a Material Definitive Agreement
On January 6, 2009, our wholly owned subsidiary Polyphenol Technologies Corporation ("PTC") gave written notice to Iowa State University Research Foundation, Inc. ("ISURF") terminating the License Agreement (ISURF #3313) between PTC and ISURF. The termination is effective April 6, 2009.
On January 6, 2009, PTC also gave written notice to Iowa State University ("ISU") terminating the Sponsored Research Agreement (ISU ID #87135) between PTC and ISU. The Termination is effective March 6, 2009.
http://biz.yahoo.com/e/090109/pyto.ob8-k.html
Anyone can start up an online auction or classified ads list as well. But the one that takes the market first is the one that reaps it. Will it be SNV? Time will tell!
http://assignments.uspto.gov/assignments/q?db=pat&asns=ULYSSES%20&page=3
I am not a pumper or basher, just seeking facts for my investment. So far I have found no assigned patents to UHDC?
Anyone know the assignment company that holds related patents?
Thanks. Do you know what the new A/S will be?
If they are going to issue an additional 47-53 million restricted, then the following statement from their website is in gross error.
* The authorized shares are pending a previously announced reduction to 80,000,000 shares, with an additional reduction predicated on the issuance of tendered SecureNetView restricted shares.
Whomever is doing the math at UHDC has room for improvement!
According to their web site, they have close to 10 million in the public float as of 9/08.
http://www.ulyssesholding.com/investor_relations.htm
Corporate Information
Share Structure as of 9/8/2008:
Authorized Shares: *100,000,000
Outstanding Shares: 38,056,924
Restricted Shares: 7,100,000
The Company Treasury: 21,200,000
Public Float: 9,756,924
* The authorized shares are pending a previously announced reduction to 80,000,000 shares, with an additional reduction predicated on the issuance of tendered SecureNetView restricted shares.
Roughly 12,000,000 shares have traded since 9/11/08. (one day after their buyback PR). If the public float is less than 10 million the pps should be rising. This company has made some pretty clear statements in their PR's which, have taken at face value regarding their technology and negotiations. They have stated that they are buying back, but that does not mean that they are not selling more than they are buying back?
I will continue to trust until proven otherwise. If they are making false and misleading statements though. It will be a serious lack of judgement on their part, with the legal ties that some shareholders have.
http://ih.advfn.com/p.php?pid=historical&cb=1223929604&symbol=NO%5EUDHC
Thanks. I snagged a few at the bid 2day.
There is around a 40 million gap between the 38 mil reportedly O/S and the 80mil A/S. Is the company currently selling any into the market? I'll probably call the TA on monday for info.
One other question for you TR47. Has the company ever mentioned pursuing hospital infant monitoring for new borns?
Thanks for taking the time to reply.
Doing a little dd here. Does anyone have any insight to
what "taking the company private" means in regards to current shareholders and their ownership in the company? Any insight would be appreciated.
From the last PR;
"The company is taking this action as an indication of its commitment to its shareholders; the company believes that its share price is non reflective of the company's true value, and as such the company has made the decision to acquire these shares and may in the future acquire the entire balance of its outstanding common shares, thus taking the company private," said James Ingram Company Spokesman.